Search hospitals > Arkansas > Little Rock
University of Arkansas for Medical Sciences
Claim this profileLittle Rock, Arkansas 72205
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Multiple Myeloma
Conducts research for Lung Cancer
Conducts research for Leukemia
843 reported clinical trials
64 medical researchers
Summary
University of Arkansas for Medical Sciences is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Cancer, Breast Cancer, Multiple Myeloma, Lung Cancer, Leukemia and other specialties. University of Arkansas for Medical Sciences is involved with conducting 843 clinical trials across 974 conditions. There are 64 research doctors associated with this hospital, such as Richard D. Hall, Heather Williams, MD, Sanjay Maraboyina, and Rangaswamy Govindarajan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Richard D. HallUniversity of Virginia Cancer Center1 year of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
17 reported clinical trials
26 drugs studied
Heather Williams, MDUniversity of Arkansas for Medical Sciences7 years of reported clinical research
Studies Adenocarcinoma
Studies Cancer
12 reported clinical trials
25 drugs studied
Sanjay MaraboyinaUniversity of Arkansas for Medical Sciences2 years of reported clinical research
Studies Lung Cancer
Studies Prostate Cancer
8 reported clinical trials
36 drugs studied
Rangaswamy GovindarajanJohn L McClellan Memorial Veterans Hospital6 years of reported clinical research
Studies Cancer
Studies Lung Cancer
9 reported clinical trials
41 drugs studied
Clinical Trials running at University of Arkansas for Medical Sciences
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Breast Cancer
Squamous Cell Carcinoma
Cancer
Lymphoma
Follicular Lymphoma
Multiple Myeloma
Lung Cancer
Melanoma
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Arkansas for Medical Sciences?
University of Arkansas for Medical Sciences is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Cancer, Breast Cancer, Multiple Myeloma, Lung Cancer, Leukemia and other specialties. University of Arkansas for Medical Sciences is involved with conducting 843 clinical trials across 974 conditions. There are 64 research doctors associated with this hospital, such as Richard D. Hall, Heather Williams, MD, Sanjay Maraboyina, and Rangaswamy Govindarajan.
Where is University of Arkansas for Medical Sciences located?
The University of Arkansas for Medical Sciences hospital is situated at 4301 W. Markham St., Little Rock, AR. For access, from I-630, exit at Pine/Cedar Street, proceed west on 7th Street to Entrance 1 at Hooper Drive. Patient drop-off is at the Spine Institute's front entrance, with self-parking in Deck 3 next to the building.
Who should I call to ask about financial aid or insurance network?
**University of Arkansas for Medical Sciences (UAMS) Hospital Financial and Insurance Inquiries**
- **Financial Aid Office**: Contact at 479-575-3806 or finaid@uark.edu for general financial aid questions. Located at 114 Silas Hunt Hall, 1 University of Arkansas, Fayetteville, AR 72701. Open Monday through Friday, 8:00 a.m. - 5:00 p.m.
- **Billing and Financial Responsibility**: For billing inquiries, use MyChart for secure messages or call 501-614-2160 / 1-800-422-3963. Mail can be sent to Customer Service, P.O. Box 251420, Little Rock, AR 72225.
- **Patient Registration (Inpatient and Outpatient)**: Call 501-686-6236 for registration-related questions.
- **Patient Financial Services**: Contact at (501) 202-3900 for information on the uninsured discount.
For financial counseling and assistance related to cancer treatment, visit the UAMS Winthrop P. Rockefeller Cancer Institute's Financial Counseling page.
What insurance does University of Arkansas for Medical Sciences accept?
The University of Arkansas for Medical Sciences (UAMS) accepts Medicaid, Medicare, and various private insurance plans. For private insurance, verify if UAMS is within your network to avoid increased out-of-pocket costs. Additionally, UAMS accepts many employer benefit programs, including UnitedHealthcare Insurance Plans, which offer supplemental health insurance for critical illnesses, hospital indemnities, and accidents.
What awards or recognition has University of Arkansas for Medical Sciences received?
The University of Arkansas for Medical Sciences (UAMS) in Little Rock, Arkansas, has seen a 14.5% increase in extramural funding in FY22, with NIH funding alone increasing 49% from FY20 to FY22. UAMS ranks 6th in NIH funding among institutions in the Institutional Development Award (IDeA) states. It has also received the President's Institutional Award for the Advancement of Telemedicine from the American Telemedicine Association, highlighting its innovative healthcare delivery to rural areas.